Outcomes of Image-Guided Moderately Hypofractionated Radiotherapy for Stage III Non-Small-Cell Lung Cancer

Table 1

Univariate and multivariate analyses of PFS in the whole 143 stage III NSCLC patients.

Characteristics	Univariate analysis			Multivariate analysis
	HR	95% CI		HR	95% CI
RT modality
Hypo-RT	1			1
Con-RT	1.55	1.03–2.32	0.034	1.62	1.07–2.43	0.021
Age
<65	1			1
≥65	1.69	1.1–2.58	0.016	1.66	1.08–2.56	0.020
Gender
Male	1
Female	0.68	0.33–1.4	0.291	NA
Tumor stage
IIIB	1
IIIA	0.68	0.33–1.4	0.291	NA
PS
0
1	1.17	0.78–1.76	0.436	NA
Pathology
Adenocarcinoma				1
Nonadenocarcinoma	1.82	1.17–2.82	0.007	1.70	1.09–2.64	0.019
Chemotherapy type
Concurrent
Sequential	1.31	0.87–1.99	0.198	NA

PFS: progression-free survival; NSCLC: non-small-cell lung cancer; RT: radiation therapy; Hypo-RT: hypofractionated RT; Con-RT: conventional RT; PS: performance status.